Editor's Note The “surgical pause”—a means of validating whether surgery is truly safe for patients deemed to be “frail” before starting a procedure—significantly reduces mortality rates and is changing practices at more than 50 Veterans Administration (VA) hospitals, the Pittsburgh Post-Gazette reported August 18. Developed by VA surgeons Daniel Hall…

Read More

Editor's Note Contradicting previous research suggesting potentially improved surgical outcomes for female surgeons, the largest analysis to date finds that gender has only a small statistical, clinically marginal correlation. Appearing in the September issue of Annals of Surgery, the study involved 4,882,784 patients operated on by 11,955 female surgeons (33%…

Read More

Editor's Note Combining dexterity and cost-effectiveness, handheld robotic devices offer potential to bridge the gap between traditional laparoscopy and more expensive robotic platforms, researchers concluded August 8 in the journal Surgery. The mini-review of clinical trials covered clinical applications of three handheld robotic devices: the HandX powered laparoscopic instrument from…

Read More

Editor's Note The US Food and Drug Administration (FDA) has designated Defibtech, LLC’s recall of RMU-2000 ARM XR Chest Compression Devices as Class 1, the most severe category indicating serious risk of injury or death. A motor issue could stop  compressions in adults whose hearts suddenly stop, according to the…

Read More

Editor's Note Recent research sheds new light on addressing two of the most pressing problems for surgical care: handoff communication failures and care bias and inequities leading to adverse—and preventable—events.   These problems are the subjects of two separate success stories in the August issue of The Joint Commission Journal…

Read More

Editor's Note The US Food & Drug Administration (FDA) has approved immunotherapy durvalumab for perioperative treatment of resectable non-small cell lung cancer (NSCLC), according to an August 15 announcement. The approval is for durvalumab (Imfinzi, AstraZeneca) in combination with platinum-based chemotherapy as a neoadjuvant treatment, followed by durvalumab alone as…

Read More

Editor's Note A recent study conducted across 185 hospital wards in England highlights the significant impact of nurse staffing levels and staff composition on patient mortality. Published August 19 in JAMA, the study analyzed data from over 626,000 hospital admissions between 2015 and 2020. It found that low staffing levels…

Read More

Editor's Note A recent study, published by Perioperative Medicine on August 13 and conducted at a large US academic tertiary care ambulatory surgery center (ASC), found the incidence of unplanned hospital admissions within 24 hours after a procedure performed at an ASC is “exceptionally” low. The research, which analyzed data…

Read More

Editor's Note As healthcare continues to transition from inpatient to outpatient settings, large health systems are increasingly forming partnerships and joint ventures to develop and manage ambulatory surgery centers (ASCs), Becker’s ASC Review August 16 reports. Per the outlet, health systems have historically been hesitant to embrace ASCs due to…

Read More

Editor's Note The percentage of new mothers without any prenatal care is rising amid an overall decline in US birth rates, according to new data from the Centers for Disease Control and Prevention (CDC). NBC News reported on the data August 21. According to the article, CDC’s National Center for…

Read More